THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

Vithayathil, Mathew;D'Alessio, Antonio;Fulgenzi, Claudia;Celsa, Ciro;Manfredi, Giulia;Nishida, Naoshi;Schoenlein, Martin;von Felden, Johann;Schulze, Kornelius;Wege, Henning;Saeed, Anwaar;Wietharn, Brooke;Hildebrand, Hannah;Wu, Linda;Ang, Celina;Marron, Thomas U.;Weinmann, Arndt;Galle, Peter R.;Bettinger, Dominik;Lin, Chun-yen;Vogel, Arndt;Scheiner, Bernhard;Lee, Pei-Chang;Huang, Yi-Hsiang;Amara, Suneetha;Muzaffar, Mahvish;Naqash, Abdul Rafeh;Zanuso, Valentina;Pressiani, Tiziana;Cabibbo, Giuseppe;Dalbeni, Andrea;Pinter, Matthias;Singal, Amit;Chon, Hong Jae;Cortellini, Alessio;Kudo, Masatoshi;Rimassa, Lorenza;Pinato, David J.;Sharma, Rohini

2024-01-01